Virgin Galactic (SPCE) 10-Q 5 Aug 21 2021 Q2 Quarterly report Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Jun. 30, 2021	Jul. 30, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2021
Document Transition Report	false
Entity File Number	001-38202
Entity Registrant Name	Virgin Galactic Holdings, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	85-3608069
Entity Address, Address Line One	166 North Roadrunner Parkway, Suite 1C
Entity Address, City or Town	Las Cruces
Entity Address, State or Province	NM
Entity Address, Postal Zip Code	88011
City Area Code	(575)
Local Phone Number	424-2100
Title of 12(b) Security	Common stock, $0.0001 par value per share
Trading Symbol	SPCE
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		257,260,827
Amendment Flag	false
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2021
Entity Central Index Key	0001706946
Current Fiscal Year End Date	--12-31

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Current assets
Cash and cash equivalents	$ 551,624	$ 665,924
Restricted cash	13,031	13,031
Inventories	29,965	30,483
Prepaid expenses and other current assets	14,990	18,489
Total current assets	609,610	727,927
Property, plant, and equipment, net	48,870	53,148
Other non-current assets	25,536	22,915
Total assets	684,016	803,990
Current liabilities:
Accounts payable	3,587	5,998
Accrued liabilities	24,364	22,982
Customer deposits	81,960	83,211
Other current liabilities	2,627	2,830
Total current liabilities	112,538	115,021
Non-current liabilities:
Warrant liability	100,347	135,440
Other long-term liabilities	25,908	26,451
Total liabilities	238,793	276,912
Commitments and contingencies (Note 15)
Stockholders' Equity
Preferred stock, $0.0001 par value; 10,000,000 authorized; none issued and outstanding	0	0
Common stock, $0.0001 par value; 700,000,000 shares authorized; 240,937,540 and 236,123,659 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	23	23
Additional paid-in capital	1,439,667	1,297,794
Accumulated deficit	(994,478)	(770,744)
Accumulated other comprehensive income	11	5
Total stockholders' equity	445,223	527,078
Total liabilities and stockholders' equity	$ 684,016	$ 803,990

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	700,000,000	700,000,000
Common stock, shares issued (in shares)	240,937,540	236,123,659
Common stock, shares outstanding (in shares)	240,937,540	236,123,659

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Income Statement [Abstract]
Revenue	$ 571	$ 0	$ 571	$ 238
Cost of revenue	63	0	63	173
Gross profit	508	0	508	65
Selling, general, and administrative expenses	38,503	26,047	83,417	52,802
Research and development expenses	35,903	37,009	72,266	71,201
Operating loss	(73,898)	(63,056)	(155,175)	(123,938)
Change in fair value of warrants	(20,363)	(9,596)	(69,082)	(326,492)
Interest income, net	214	498	532	1,666
Other income, net	13	221	40	49
Loss before income taxes	(94,034)	(71,933)	(223,685)	(448,715)
Income tax (expense) benefit	(6)	(40)	(49)	6
Net loss	(94,040)	(71,973)	(223,734)	(448,709)
Other comprehensive loss:
Foreign currency translation adjustment	(19)	0	8	(54)
Total comprehensive loss	$ (94,059)	$ (71,973)	$ (223,726)	$ (448,763)
Net loss per share:
Basic (in dollars per share)	$ (0.39)	$ (0.34)	$ (0.94)	$ (2.17)
Diluted (in dollars per share)	$ (0.39)	$ (0.34)	$ (0.94)	$ (2.17)
Weighted-average shares outstanding
Basic (in shares)	240,733,497	211,784,541	238,774,515	207,097,047
Diluted (in shares)	240,733,497	211,784,541	238,774,515	207,097,047

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Equity - USD ($) $ in Thousands	Total	Preferred Stock	Common Stock	Additional paid-in capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2019	$ 343,230	$ 0	$ 20	$ 469,008	$ (125,857)	$ 59
Beginning balance (in shares) at Dec. 31, 2019		0	196,001,038
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(376,736)				(376,736)
Other comprehensive income (loss)	(54)					(54)
Common stock issued related to warrants exercised (in shares)			13,239,934
Common stock issued related to warrants exercised	341,001		$ 1	341,000
Stock-based compensation	4,425			4,425
Ending balance at Mar. 31, 2020	311,866	$ 0	$ 21	814,433	(502,593)	5
Ending balance (in shares) at Mar. 31, 2020		0	209,240,972
Beginning balance at Dec. 31, 2019	343,230	$ 0	$ 20	469,008	(125,857)	59
Beginning balance (in shares) at Dec. 31, 2019		0	196,001,038
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(448,709)
Ending balance at Jun. 30, 2020	264,389	$ 0	$ 21	838,929	(574,566)	5
Ending balance (in shares) at Jun. 30, 2020		0	210,403,856
Beginning balance at Mar. 31, 2020	311,866	$ 0	$ 21	814,433	(502,593)	5
Beginning balance (in shares) at Mar. 31, 2020		0	209,240,972
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(71,973)				(71,973)
Common stock issued related to warrants exercised (in shares)			1,162,884
Common stock issued related to warrants exercised	19,741			19,741
Stock-based compensation	5,525			5,525
Transaction costs	(770)			(770)
Ending balance at Jun. 30, 2020	264,389	$ 0	$ 21	838,929	(574,566)	5
Ending balance (in shares) at Jun. 30, 2020		0	210,403,856
Beginning balance at Dec. 31, 2020	527,078	$ 0	$ 23	1,297,794	(770,744)	5
Beginning balance (in shares) at Dec. 31, 2020		0	236,123,659
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(129,694)				(129,694)
Other comprehensive income (loss)	26					26
Stock-based compensation	22,111			22,111
Issuance of common stock pursuant to stock-based compensation, net of withholding taxes (in shares)			1,150,771
Issuance of common stock pursuant to stock-based compensation, net of withholding taxes	323			323
Ending balance at Mar. 31, 2021	419,844	$ 0	$ 23	1,320,228	(900,438)	31
Ending balance (in shares) at Mar. 31, 2021		0	237,274,430
Beginning balance at Dec. 31, 2020	527,078	$ 0	$ 23	1,297,794	(770,744)	5
Beginning balance (in shares) at Dec. 31, 2020		0	236,123,659
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(223,734)
Ending balance at Jun. 30, 2021	445,223	$ 0	$ 23	1,439,667	(994,478)	11
Ending balance (in shares) at Jun. 30, 2021		0	240,937,540
Beginning balance at Mar. 31, 2021	419,844	$ 0	$ 23	1,320,228	(900,438)	31
Beginning balance (in shares) at Mar. 31, 2021		0	237,274,430
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(94,040)				(94,040)
Other comprehensive income (loss)	(20)					(20)
Common stock issued related to warrants exercised (in shares)			3,387,827
Common stock issued related to warrants exercised	104,176			104,176
Stock-based compensation	14,423			14,423
Issuance of common stock pursuant to stock-based compensation, net of withholding taxes (in shares)			275,283
Issuance of common stock pursuant to stock-based compensation, net of withholding taxes	840			840
Ending balance at Jun. 30, 2021	$ 445,223	$ 0	$ 23	$ 1,439,667	$ (994,478)	$ 11
Ending balance (in shares) at Jun. 30, 2021		0	240,937,540

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Cash flows from operating activities
Net loss	$ (94,040)	$ (71,973)	$ (223,734)	$ (448,709)
Stock-based compensation			36,535	9,950
Depreciation and amortization	2,900	2,500	5,740	4,489
Change in fair value of warrant liability	20,363	9,596	69,082	326,492
Other operating activities, net			(17)	67
Change in assets and liabilities
Inventories			518	(1,987)
Other current and non-current assets			319	3,261
Accounts payable and accrued liabilities			(751)	(914)
Customer deposits			(1,252)	(1,628)
Other current and non-current liabilities			88	892
Net cash used in operating activities			(113,472)	(108,087)
Cash flows from investing activity
Capital expenditures			(1,647)	(9,940)
Cash used in investing activity			(1,647)	(9,940)
Cash flows from financing activities
Payments of finance lease obligations			(69)	(49)
Proceeds from issuance of common stock pursuant to stock options exercised			12,965	0
Transaction costs			(274)	(1,467)
Withholding taxes paid on behalf of employees on net settled stock-based awards			(11,803)	0
Net cash provided by (used in) financing activities			819	(1,516)
Net decrease in cash and cash equivalents			(114,300)	(119,543)
Cash, cash equivalents and restricted cash at beginning of period			678,955	492,721
Cash, cash equivalents and restricted cash at end of period	564,655	373,178	564,655	373,178
Cash and cash equivalents	551,624	359,912	551,624	359,912
Restricted cash	13,031	13,266	13,031	13,266
Cash, cash equivalents and restricted cash	$ 564,655	$ 373,178	$ 564,655	$ 373,178

Organization and its wholly own

Organization and its wholly owned subsidiaries ("VGH, Inc.")	6 Months Ended
	Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and its wholly owned subsidiaries ("VGH, Inc.")	Organization and its wholly owned subsidiaries ("VGH, Inc.") Virgin Galactic Holdings, Inc. and its wholly owned subsidiaries ("VGH, Inc."), in this report as "we," "us," "our," the "Company" and similar terms, are focused on the development, manufacture and operations of spaceships and related technologies for the purpose of conducting commercial human spaceflight and flying commercial research and development payloads into space. The development and manufacturing activities are located in Mojave, California with plans to operate the commercial spaceflights out of Spaceport America located in New Mexico. Global Pandemic On March 11, 2020, the World Health Organization characterized the outbreak of COVID-19 as a global pandemic and recommended containment and mitigation measures. Since then, extraordinary actions have been taken by international, federal, state, and local public health and governmental authorities to contain and combat the outbreak and spread of COVID-19 in regions throughout the world. These actions include travel bans, quarantines, “stay-at-home” orders, and similar mandates for many individuals to substantially restrict daily activities and for many businesses to curtail or cease normal operations. Consistent with the actions taken by governmental authorities, including US Federal, California, New Mexico and the United Kingdom, where most of our workforce is located, we have taken appropriately cautious steps to protect our workforce and support community efforts. As part of these efforts, and in accordance with applicable government directives, we initially reduced and then temporarily suspended on-site operations at our facilities in Mojave, California and Spaceport America, New Mexico in March 2020. Starting late March 2020, approximately two-thirds of our employees and contractors were able to complete their duties from home, which enabled much critical work to continue, including engineering analysis and drawing releases for VSS Unity, VMS Eve and the second SpaceShipTwo vehicle, process documentation updates, as well as workforce training and education. The remaining one-third of our workforce was unable to perform their normal duties from home. In April 2020, in accordance with our classification within the critical infrastructure designation, we resumed limited operations under revised operational and manufacturing plans that conformed to the COVID-19 health precautions at that time. This included universal facial covering requirements, rearranging facilities to follow social distancing protocols, conducting active daily temperature checks and undertaking regular and thorough disinfecting of surfaces and tools. We also tested employees and contractors for COVID-19 on a regular basis. As the pandemic has evolved, we have continued to follow US Federal, State and UK guidance, as applicable to our sites. However, the COVID-19 pandemic and the continued precautionary actions taken related to COVID-19 have adversely impacted, and are expected to continue to adversely impact, our operations, including the completion of the development of our spaceflight systems and our scheduled spaceflight test programs. As of the date of this quarterly report on Form 10-Q, all our employees whose work requires them to be in our facilities are now back on-site, but we have experienced, and expect to continue to experience, reductions in operational efficiency due to illness from COVID-19 and precautionary actions taken related to COVID-19. For the time being, we are encouraging those employees who are able to work from home to continue doing so. The COVID-19 pandemic and the protocols and procedures we have implemented in response to the pandemic have caused some delays in operational and maintenance activities, including delays in our test flight program. The full impact of the COVID-19 pandemic on our business and results of operations subsequent to June 30, 2021 will depend on future developments, such as the ultimate duration and scope of the pandemic and its impact on our operations necessary to complete the development of our spaceflight systems, our scheduled spaceflight test programs and commencement of our commercial flights. In addition to existing travel restrictions, countries may continue to maintain or reimpose closed borders, impose prolonged quarantines, or further restrict travel. We believe our cash and cash equivalents on hand at June 30, 2021, and management's operating plan, will provide sufficient liquidity to fund our operations for at least the next twelve months from the issuance of these financial statements. Restatement of Previously Issued Financial Statements Warrant liability As previously disclosed in Amendment No. 2 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2020 (the "Amendment No. 2 to Form 10-K"), the Company has restated its financial statements as of December 31, 2020 and 2019, for the years ended December 31, 2020 and 2019, as well as the summarized unaudited quarterly financial data for each of the quarterly periods from March 31, 2019 through December 31, 2020, to correct misstatements in those prior periods related to the accounting for warrants, under the guidance of Accounting Standards Codification (“ASC”) 815-40, Contracts in Entity’s Own Equity. The following tables represent the estimated fair value of the Company’s public and private warrant liabilities recorded on our balance sheet along with changes in fair value which are recorded as other income and expense on our statement of operations and the fair value of common stock issued on the date of exercise, which were recorded as additional paid in capital. Public Warrants Private Placement Warrants Total (In thousands) Warranty Liability at December 31, 2019 77,050 47,280 124,330 Redemption/Exercise of Warrants (341,001) — (341,001) Change in Fair Value 283,296 33,600 316,896 Warrant Liability at March 31, 2020 19,345 80,880 100,225 Redemption/Exercise of Warrants (19,741) (19,741) Change in Fair Value 396 9,200 9,596 Warrant Liability at June 30, 2020 — 90,080 90,080 Warranty Liability at December 31, 2020 — 135,440 135,440 Change in Fair Value — 48,719 48,719 Warrant Liability at March 31, 2021 — 184,159 184,159 Redemption/Exercise of Warrants — (104,175) (104,175) Change in Fair Value — 20,363 20,363 Warrant Liability at June 30, 2021 — 100,347 100,347

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting PoliciesBasis of PresentationThese condensed consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). All intercompany transactions and balances between the various legal entities comprising the Company have been eliminated in consolidation. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.Use of EstimatesThe preparation of the consolidated financial statements in conformity with GAAP required us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We base these estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results may differ materially from these estimates. Significant estimates inherent in the preparation of the consolidated financial statements include, but are not limited to, accounting for revenue, cost of revenue, contract assets, contract liabilities, useful lives of property, plant and equipment, net, accrued liabilities, income taxes including deferred tax assets and liabilities and impairment valuation, warrants, stock-based awards and contingencies.Revenue Recognition We recognize revenue when control of the promised service is transferred to our customers in an amount that reflects the consideration we expect to receive based on the contracted amount for those services. Our contracts generally include spaceflight operations and other revenue and engineering services revenue. Spaceflight operations and other revenue Spaceflight operations and other revenue is recognized for providing human spaceflights and carrying payload cargo into space, or a combination of the two. In addition, we have various sponsorship arrangements for which revenue is recognized over the sponsorship term. Human spaceflight services are those services provided to the majority of our customers. Spaceflight service revenue is recognized at a point in time upon successful completion of a spaceflight. Payload cargo services generally include performance obligations in which control is transferred over time. We recognize revenue on these fixed fee contracts, over time, using the proportion of actual costs incurred to the total costs expected to complete the performance obligations. In contracts which include a combination of services, the Company assesses and accounts for individual services separately if they are distinct performance obligations, which often requires judgment based upon knowledge of the services and structure of the sales contract. We allocate the contract price to each performance obligation based on the estimated standalone selling price using observable pricing from our contracts with single performance obligations. Engineering services revenue Engineering services revenue is recognized for providing services for the research, design, development, manufacture, integration and sustainment of advanced technology aerospace systems, products and services. We have arrangements as a subcontractor to the primary contractor of a long-term contract with the U.S. Government and perform the specified work on a time-and-materials basis subject to a guaranteed maximum price. Our engineering services revenue contract obligates us to provide services that together are one distinct performance obligation; the delivery of engineering services. The Company elected to apply the ‘as-invoiced’ practical expedient to such revenues, and as a result, will bypass estimating the variable transaction price. Revenue is recognized as control of the performance obligation is transferred over time to the customer. Variable consideration We generally estimate variable consideration and refund liabilities at the most likely amount to which we expect to be entitled or owed and in certain cases based on the expected value, which requires judgment. Estimated variable consideration amounts are included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. Estimated refund liability amounts are excluded in the transaction price to the extent it is probable that they are payable to the customer. Our estimates of variable consideration and refund liabilities, and determination of whether to include the estimated amounts in the transaction price are based largely on an assessment of our anticipated performance and all information that is reasonably available to us. Disaggregation of revenue The Company does not disaggregate revenue for purposes of disclosure. Contract balances Contract assets are comprised of billed accounts receivable and unbilled receivables, which is the result of timing of revenue recognition, billings and cash collections. The Company records accounts receivable when it has an unconditional right to consideration. Contract liabilities relate to spaceflight operations and other revenue contracts and are recorded when cash payments are received or due in advance of performance. Cash payments for spaceflight services are classified as customer deposits until enforceable rights and obligations exist, when such deposits also become nonrefundable. Customer deposits become nonrefundable and are recorded as deferred revenue following the Company's delivery of the conditions of carriage to the customer and execution of an informed consent. As of June 30, 2021 and December 31, 2020, our contract liabilities are 82.0 million and $83.2 million, respectively. As of June 30, 2021, the contract liabilities are comprised of customer deposits for our spaceflight services of $81.7 million and $0.3 million for our payload contracts. As of December 31, 2020, the contract liabilities are comprised of customer deposits for our spaceflight services of $82.7 million and $0.6 million for our payload contracts. Contract fulfillment costs The Company evaluates whether or not we should capitalize the costs of fulfilling a contract. Such costs would be capitalized when they are not within the scope of other standards and: (1) are directly related to a contract; (2) generate or enhance resources that will be used to satisfy performance obligations; and (3) are expected to be recovered. Significant financing component In determining the transaction price, the Company adjusts the promised amount of consideration for the effects of the time value of money when the timing of payments provides it with a significant benefit of financing the transfers of goods or services to the customer. In those circumstances, the contract contains a significant financing component. When adjusting the promised amount of consideration for a significant financing component, the Company uses the discount rate that would be reflected in a separate financing transaction between the entity and its customer at contract inception and recognizes the revenue amount on a straight-line basis over the term of the Customer Agreement, and interest expense using the effective interest rate method. When the time period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service is not more than one year, the Company applies the significant financing component practical expedient and do not adjust the promised amount of consideration. Remaining performance obligations We do not disclose information about remaining performance obligations for (a) contracts with an original expected length of one year or less, (b) revenues recognized at the amount at which we have the right to invoice for services performed, or (c) variable consideration allocated to wholly unsatisfied performance obligations. The Company classifies its public and private placement warrants as liabilities in accordance with ASC 815 (Derivatives and Hedging). The warrant liability is recorded on the consolidated balance sheet at fair value on the issue date, with subsequent changes in their fair value recognized in the consolidated statement of operations at each reporting date. The Company determined the fair value of its public warrants, which traded in active markets, using quoted market prices for identical instruments. The Company determines the fair value of the private placement warrants using a Black-Scholes option model and the quoted price of the Company’s common stock in an active market, a Level 3 measurement. Volatility is based on the actual market activity of the Company’s peer group as well as the Company's historical volatility since the Virgin Galactic Business Combination. The expected life is based on the remaining contractual term of the warrants, and the risk free interest rate is based on the implied yield available on U.S. Treasury Securities with a maturity equivalent to the warrants’ expected life. (f) Other Summary of Significant Accounting Policies There have been no other significant changes from the significant accounting policies disclosed in Note 2 of the “Notes to Consolidated Financial Statements” included in the Company's Amendment No. 2 to Form 10-K.

Recent Accounting Pronouncement

Recent Accounting Pronouncements	6 Months Ended
	Jun. 30, 2021
Accounting Changes and Error Corrections [Abstract]
Recent Accounting Pronouncements	Recent Accounting Pronouncements Changes to GAAP are established by the Financial Accounting Standards Board (“FASB”) in the form of Accounting Standards Updates (“ASU”). (a) Issued Accounting Standard Updates Not Yet Adopted In August 2020, the FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity , which simplifies and clarifies certain calculation and presentation matters related to convertible and equity and debt instruments. Specifically, ASU-2020-06 removes requirements to separately account for conversion features as a derivative under ASC Topic 815 and removing the requirement to account for beneficial conversion features on such instruments. Accounting Standards Update 2020-06 also provides clearer guidance surrounding disclosure of such instruments and provides specific guidance for how such instruments are to be incorporated in the calculation of Diluted EPS. The guidance under ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. The Company is currently evaluating the impact of ASU 2020-06 to its financial statements. In January 2021, the FASB issued ASU 2021-01 - Reference Rate Reform , which clarifies that certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivatives that are affected by the discounted transition. This update is effective immediately. We have evaluated and determined the update has no impact to the Company's condensed consolidated financial statements. In May 2021, the FASB issued ASU 2021-04, Earning Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic 470-50), Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40), which clarified and reduced diversity in an issuer's accounting for modifications of exchanges of freestanding equity-classified written call options (such as warrants) that remain equity classified after modification or exchange. This update is effective for all entities for fiscal years beginning after December 15, 2021. We are currently evaluating the impact of ASU 2021-04 to our condensed consolidated financial statements. (b) Adopted Accounting Standard Updates In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes. In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740) , which affects general principles within Topic 740, and are meant to simplify and reduce the cost of accounting for income taxes. It removes certain exceptions to the general principles in Topic 740 and simplifies areas including franchise taxes that are partially based on income, transactions with a government that result in a step up in the tax basis of goodwill, the incremental approach for intraperiod tax allocation, interim period income tax accounting for year-to-date losses that exceed anticipated losses and enacted changes in tax laws in interim periods. The Company adopted the new guidance effective January 1, 2021. The adoption of the new guidance did not have a material impact to the Company's condensed consolidated financial statements.

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jun. 30, 2021
Related Party Transactions [Abstract]
Related Party Transactions	Related Party TransactionsThe Company licenses its brand name from certain entities affiliated with Virgin Enterprises Limited (“VEL”), a company incorporated in England. VEL is an affiliate of the Company. Under the trademark license, the Company has the exclusive right to operate under the brand name “Virgin Galactic” worldwide. Royalty payables, excluding sponsorship royalties, for the use of license are the greater of 1% of revenue or $40,000 per quarter, prior to the commercial launch date. Sponsorship royalties payable are 25% of sponsorship revenue. We paid license and royalty fees of $40,000 and $40,000 for the three months ended June 30, 2021 and 2020, respectively. We paid license and royalty fees of $80,000 and $95,000 for the six months ended June 30, 2021 and 2020, respectively The Company has a Transition Services Agreement ("TSA") with Virgin Orbit, LLC ("VO") based on an allocation methodology that considers our headcount, unless directly attributable to the business. The Company is allocated operating expense from VO Holdings, Inc. and its subsidiaries (“VOH”), a majority owned company of GV for operations-related functions based on an allocation methodology that considers our headcount, unless directly attributable to the business. Operating expense allocations include use of machinery and equipment, pilot services, and other general administrative expenses. We were allocated $31,000 and $99,000 of operating expenses, net, from VOH for the three months ended June 30, 2021 and 2020, respectively. We were allocated $71,000 and $236,000 of operating expenses, net, from VOH for the six months ended June 30, 2021 and 2020, respectively. The Company has a receivable (payable) from VOH of $2,000 and $85,000 as of June 30, 2021 and December 31, 2020, respectively.

Inventory

Inventory	6 Months Ended
	Jun. 30, 2021
Inventory Disclosure [Abstract]
Inventory	InventoryAs of June 30, 2021 and December 31, 2020, inventory is comprised of the following: As of June 30, 2021 December 31, 2020 (Unaudited) (In thousands) Raw Materials $ 21,938 $ 22,963 Spare parts 8,027 7,520 Total inventory $ 29,965 $ 30,483 For the three months ended June 30, 2021 and June 30, 2020, we wrote off $0.1 million and $0.1 million of inventory due to excess and obsolescence, respectively. For the six months ended June 30, 2021 and June 30, 2020, we wrote off $0.2 million and $1.1 million of inventory due to excess and obsolescence, respectively.

Property, Plant, and Equipment,

Property, Plant, and Equipment, net	6 Months Ended
	Jun. 30, 2021
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment, net	Property, Plant, and Equipment, net As of June 30, 2021 and December 31, 2020, property, plant, and equipment, net consisted of the following: As of June 30, 2021 December 31, 2020 (Unaudited) (In thousands) Buildings $ 9,117 $ 9,142 Leasehold improvements 28,914 28,744 Aircraft 195 195 Machinery and equipment 35,709 34,330 IT software and equipment 23,011 22,042 Construction in progress 655 1,780 97,601 96,233 Less accumulated depreciation and amortization (48,731) (43,085) Property, plant, and equipment, net $ 48,870 $ 53,148 Total depreciation and amortization for the three months ended June 30, 2021 and 2020 was $2.9 million and $2.5 million, respectively, of which $1.3 million and $1.1 million was recorded in research and development expense, respectively. Total depreciation and amortization for the six months ended June 30, 2021 and 2020 was $5.7 million and $4.5 million, respectively, of which $2.6 million and $2.1 million was recorded in research and development expense, respectively.

Leases

Leases	6 Months Ended
	Jun. 30, 2021
Leases [Abstract]
Leases	Leases The Company's leases are more fully described in Note 8 of the "Notes to Consolidated Financial Statements" to its Amendment No. 2 to Form 10-K. The components of lease expense related to leases for the periods presented below are as follows: Three Months Ended 2021 2020 (Unaudited and in thousands) Lease Cost: Operating lease expense $ 1,254 $ 1,010 Short-term lease expense 8 26 Finance Lease Cost: Amortization of right-of-use assets 35 28 Interest on lease liabilities 7 8 Total finance lease cost 42 36 Variable lease cost 1,372 427 Total lease cost $ 2,676 $ 1,499 Six Months Ended 2021 2020 (Unaudited and in thousands) Lease Cost: Operating lease expense $ 2,514 $ 2,162 Short-term lease expense 20 123 Finance Lease Cost: Amortization of right-of-use assets 69 55 Interest on lease liabilities 14 17 Total finance lease cost 83 72 Variable lease cost 2,710 775 Total lease cost $ 5,327 $ 3,132 The components of supplemental cash flow information related to leases for the period are as follows: Six Months Ended June 30, 2021 2020 (In thousands, except term and rate data) Cash flow information: Operating cash flows for operating leases $ 2,712 $ 2,545 Operating cash flows for finance leases $ 14 $ 18 Financing cash flows for finance leases $ 69 $ 49 Non-cash activity: Right-of-use assets obtained in exchange for lease obligations Operating leases $ 501 $ 34 Finance Leases $ 19 $ 48 Other Information: Weighted average remaining lease term: Operating leases (in years) 12.37 13.20 Finance leases (in years) 2.49 3.47 Weighted average discount rates: Operating leases 11.65 % 11.77 % Finance leases 8.26 % 8.92 % The supplemental balance sheet information related to leases for the period is as follows: As of June 30, 2021 December 31, 2020 (Unaudited) (In thousands) Operating leases Long-term right-of-use assets $ 19,055 $ 19,555 Short-term operating lease liabilities $ 2,138 $ 2,384 Long-term operating lease liabilities 23,701 24,148 Total operating lease liabilities $ 25,839 $ 26,532 Commitments The Company has certain non-cancelable operating leases primarily for its premises. These leases generally contain renewal options for periods ranging from 3 to 20 years and require the Company to pay all executory costs, such as maintenance and insurance. Certain lease arrangements have rent free periods or escalating payment provisions, and we recognize rent expense of such arrangements on a straight line basis. Future minimum lease payments under non-cancelable operating leases (with initial or remaining lease terms in excess of one year) and future minimum finance lease payments as of June 30, 2021 are as follows: Operating Leases Finance (In thousands) 2021 (for the remaining period) $ 4,948 $ 157 2022 4,001 119 2023 3,969 79 2024 3,891 — 2025 3,833 — Thereafter 28,936 — Total lease payments $ 49,578 $ 355 Less: Imputed interest/present value discount (23,739) $ (33) Present value of lease liabilities $ 25,839 $ 322
Leases	Leases The Company's leases are more fully described in Note 8 of the "Notes to Consolidated Financial Statements" to its Amendment No. 2 to Form 10-K. The components of lease expense related to leases for the periods presented below are as follows: Three Months Ended 2021 2020 (Unaudited and in thousands) Lease Cost: Operating lease expense $ 1,254 $ 1,010 Short-term lease expense 8 26 Finance Lease Cost: Amortization of right-of-use assets 35 28 Interest on lease liabilities 7 8 Total finance lease cost 42 36 Variable lease cost 1,372 427 Total lease cost $ 2,676 $ 1,499 Six Months Ended 2021 2020 (Unaudited and in thousands) Lease Cost: Operating lease expense $ 2,514 $ 2,162 Short-term lease expense 20 123 Finance Lease Cost: Amortization of right-of-use assets 69 55 Interest on lease liabilities 14 17 Total finance lease cost 83 72 Variable lease cost 2,710 775 Total lease cost $ 5,327 $ 3,132 The components of supplemental cash flow information related to leases for the period are as follows: Six Months Ended June 30, 2021 2020 (In thousands, except term and rate data) Cash flow information: Operating cash flows for operating leases $ 2,712 $ 2,545 Operating cash flows for finance leases $ 14 $ 18 Financing cash flows for finance leases $ 69 $ 49 Non-cash activity: Right-of-use assets obtained in exchange for lease obligations Operating leases $ 501 $ 34 Finance Leases $ 19 $ 48 Other Information: Weighted average remaining lease term: Operating leases (in years) 12.37 13.20 Finance leases (in years) 2.49 3.47 Weighted average discount rates: Operating leases 11.65 % 11.77 % Finance leases 8.26 % 8.92 % The supplemental balance sheet information related to leases for the period is as follows: As of June 30, 2021 December 31, 2020 (Unaudited) (In thousands) Operating leases Long-term right-of-use assets $ 19,055 $ 19,555 Short-term operating lease liabilities $ 2,138 $ 2,384 Long-term operating lease liabilities 23,701 24,148 Total operating lease liabilities $ 25,839 $ 26,532 Commitments The Company has certain non-cancelable operating leases primarily for its premises. These leases generally contain renewal options for periods ranging from 3 to 20 years and require the Company to pay all executory costs, such as maintenance and insurance. Certain lease arrangements have rent free periods or escalating payment provisions, and we recognize rent expense of such arrangements on a straight line basis. Future minimum lease payments under non-cancelable operating leases (with initial or remaining lease terms in excess of one year) and future minimum finance lease payments as of June 30, 2021 are as follows: Operating Leases Finance (In thousands) 2021 (for the remaining period) $ 4,948 $ 157 2022 4,001 119 2023 3,969 79 2024 3,891 — 2025 3,833 — Thereafter 28,936 — Total lease payments $ 49,578 $ 355 Less: Imputed interest/present value discount (23,739) $ (33) Present value of lease liabilities $ 25,839 $ 322

Accrued Expenses

Accrued Expenses	6 Months Ended
	Jun. 30, 2021
Payables and Accruals [Abstract]
Accrued Expenses	Accrued Expenses A summary of the components of accrued liabilities are as follows: As of June 30, 2021 December 31, 2020 (Unaudited) (In thousands) Accrued bonus 6,258 6,892 Other accrued expenses 18,106 16,090 Total accrued expenses $ 24,364 $ 22,982

Long-term Debt

Long-term Debt	6 Months Ended
	Jun. 30, 2021
Debt Disclosure [Abstract]
Long-term Debt	Long-term Debt As of June 30, 2021 December 31, 2020 (Unaudited) (In thousands) Commercial loan $ 620 $ 620 620 620 Less: Current portion (310) (310) Non-current portion $ 310 $ 310 Aggregate maturities of long-term debt as of June 30, 2021 are as follows: (In thousands) 2021 (for the remaining period) $ 310 2022 310 $ 620 On June 18, 2020, we financed the purchase of software licenses through a loan totaling approximately $0.9 million. The loan amortized in three equal annual installment of approximately $0.3 million with the final payment due on October 1, 2022 with 0% interest rate. The loan is secured by a standby letter of credit issued from our financial institution and restricted cash has been recorded for the corresponding outstanding balance. The imputed interest of this loan was immaterial.

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2021
Income Tax Disclosure [Abstract]
Income Taxes	Income TaxesIncome tax expense was $6,000 and 40,000 for the three months ended June 30, 2021 and 2020, respectively. Income tax (expense) benefit was $(49,000) and $6,000 for the six months ended June 30, 2021 and 2020, respectively. The effective income tax rate was nil for three months ended June 30, 2021 and 2020. The effective income tax rate was nil for six months ended June 30, 2021 and 2020. Our effective tax rate differs from the U.S. statutory rate primarily due to a substantially full valuation allowance against our net deferred tax assets where it is more likely than not that some or all of the deferred tax assets will not be realized.

Stockholders' Equity

Stockholders' Equity	6 Months Ended
	Jun. 30, 2021
Equity [Abstract]
Stockholders' Equity	Stockholders' Equity There have been no significant changes from the Stockholders' Equity disclosed in Note 11 of the “Stockholders Equity” included in the Amendment No. 2 Form 10-K other than the issuance of common stock and redemption of warrants as noted below. Stockholders' Agreement In connection with the closing of the Virgin Galactic Business Combination, the Company entered into a stockholders’ agreement with certain of the Company’s investors. Pursuant to the terms of the Stockholders’ Agreement, as long as Virgin Investments Limited (VIL) is entitled to designate two directors to the Company’s Board of Directors, the Company must obtain VIL’s prior written consent to engage in certain corporate transactions and management functions such as business combinations, disposals, acquisitions, incurring indebtedness, and engagement of professional advisors, among others. Warrants and Warrant Redemption Public warrants were initially issued as part of SCH's initial public offering in 2017 and assumed upon the consummation of the Business Combination. As of June 30, 2021, there were no public warrants outstanding. As of June 30, 2021 and December 31, 2020, there were 2,666,667 and 8,000,000 warrants outstanding, respectively, that were issued in a private placement simultaneously with the Company’s initial public offering (the “private placement warrants”). All remaining outstanding warrants were redeemed through cashless exercise in July 2021. Under the terms of the warrant agreement (the “Warrant Agreement”) between us and Continental Stock Transfer & Trust Company, as warrant agent, the public warrants became exercisable on a cashless basis on January 27, 2020, based on the exchange ratio as calculated under the Warrant Agreement at the time of the exercise. On March 13, 2020 and pursuant to the terms of the Warrant Agreement, we announced that all public warrants that remained unexercised immediately after 5:00 p.m. New York City time on April 13, 2020 (the “Redemption Date”) would be redeemed for $0.01 per warrant. Warrant holders could exercise their public warrants at any time from March 13, 2020 and prior to the Redemption Date on a cashless basis, and receive 0.5073 shares of common stock per public warrant surrendered for exercise. Immediately after the Redemption Date, 295,305 public warrants remained unexercised and were redeemed at a redemption price of $0.01 per public warrant in accordance with the terms of the Warrant Agreement. The private placement warrants were not subject to the redemption and remain outstanding as of June 30, 2021. The Company determined that both the public warrants and the private placement warrants (the "Warrants") should be classified as a liability in accordance with ASC 480. The Company remeasures the fair value of the Warrants at each reporting date with changes recorded in earnings. In connection with the Company's remeasurement of the Warrants to fair value, the Company recorded expense of approximately $20.4 million and $9.6 million for the three months ended June 30, 2021 and 2020, respectively, and $69.1 million and $326.5 million for the six months ended June 30, 2021 and 2020, respectively. The fair value of the warrant liability is approximately $100.3 million and $135.4 million as of June 30, 2021 and December 31, 2020, respectively. The private placement warrants are classified as Level 3 financial instruments. See Note 14. Fair Value Measurements .

Earnings Per Share

Earnings Per Share	6 Months Ended
	Jun. 30, 2021
Earnings Per Share [Abstract]
Earnings Per Share	Earnings per Share The following table presents net loss per share and related information: Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 (As Restated) (As Restated) (In thousands, except for share and per share data) Basic and diluted: Net loss $ (94,040) $ (71,973) $ (223,734) $ (448,709) Weighted average shares of common stock outstanding 240,733,497 211,784,541 238,774,515 207,097,047 Basic and diluted net loss per share $ (0.39) $ (0.34) $ (0.94) $ (2.17) As of June 30, 2021 and June 30, 2020, the Company has excluded the potential effect of warrants to purchase shares of common stock totaling 2,666,667 and 8,000,000, respectively, shares and the dilutive effect of outstanding stock options and unvested restricted stock units, as described in Note 12 of the “Notes to Consolidated Financial Statements” included in the 2020 Amendment No. 2 to Form 10-K, in the calculation of diluted loss per share, as the effect would be anti-dilutive due to losses incurred.

Stock-Based Compensation

Stock-Based Compensation	6 Months Ended
	Jun. 30, 2021
Share-based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation The Company's 2019 Incentive Award Plan ("2019 Plan") is more fully described in Note 13 of the "Notes to Consolidated Financial Statements" in the Amendment No. 2 to Form 10-K. Under the 2019 Plan, the Company has the ability to grant incentive stock options, non-qualified stock options and restricted stock units ("RSU") to employees, directors and other service providers. Performance stock units ("PSU") are RSUs that vest based on the achievement of specified performance criteria. Twenty five percent of such stock options cliff vest at the grant dates first anniversary and will ratably vest monthly over the next three years, subject to continued employment on each vesting date. Vested options will be exercisable at any time until ten years from the grant date, subject to earlier expiration under certain terminations of service and other conditions. The stock options granted have an exercise price equal to the closing stock price of our common stock on the grant date. Stock Option Units The following table sets forth the summary of options activity for the six month ended June 30, 2021 under the 2019 Plan (dollars in thousands except per share data): Number of Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Life (in years) Aggregate Intrinsic Value (1) Options outstanding at December 31, 2020 6,796,045 $ 13.59 8.64 68,888 Granted — — Exercised (1,013,402) 13.01 Forfeited options (588,999) 13.93 Options outstanding at June 30, 2021 5,193,644 $ 13.67 7.53 167,604 Options exercisable at June 30, 2021 1,916,745 $ 13.49 7.34 62,305 (1) Aggregate intrinsic value is calculated based on the difference between our closing stock price at period end and the exercise price, multiplied by the number of in-the-money options and represents the pre-tax amount that would have been received by the option holders, had they all exercised all their options on the period end date. Restricted Stock Units The RSUs vest over four years with 25% cliff vest at the first year anniversary of the grant date and ratably over the next three years. The following table sets forth the summary of RSUs activity during the six months ended June 30, 2021 under the 2019 Plan (dollars in thousands except per share data): Shares Weighted Average Fair Value Outstanding at December 31, 2020 4,760,784 $ 19.63 Granted 680,784 40.41 Vested (709,404) 16.20 Forfeited (713,766) 16.72 Outstanding at June 30, 2021 4,018,398 $ 24.21 Performance Stock Units In March 2021, the Company granted a total of 84,626 PSUs to our executive officers. Between 25% and 200% of the PSUs are eligible to vest based on the achievement of certain performance goals by specified target dates. The fair value of these PSUs is calculated based on the market value of the Company's common stock on the grant date. These PSUs are amortized over the requisite service period in which it is probable that the performance goal is achieved. The following table summarizes the details of the performance stock units: Shares Weighted Average Fair Value PSUs outstanding at December 31, 2020 — $ — Granted 84,626 29.88 PSUs outstanding at June 30, 2021 84,626 $ 29.88 Stock options, RSUs and PSUs expenses are included in selling, general and administrative and research and development expense in the Condensed Consolidated Statements of Operations and Comprehensive Loss as follows: Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Stock option expense Selling, General & Administrative 1,870 1,880 10,856 3,944 Research & Development 825 1,017 1,668 2,056 Total stock option expense 2,695 2,897 12,524 6,000 RSU expense Selling, General & Administrative 7,982 1,666 17,035 2,473 Research & Development 3,172 962 6,402 1,477 Total RSU expense 11,154 2,628 23,437 3,950 PSU expense Selling, General & Administrative $ 574 $ — $ 574 $ — Total PSU expense $ 574 $ — $ 574 $ — Total stock-based compensation expense $ 14,423 $ 5,525 $ 36,535 $ 9,950 As of June 30, 2021, the unrecognized stock-based compensation related to stock options was $28.9 million and is expected to be recognized over a weighted-average period of 2.7 years. At June 30, 2021, the unrecognized stock-based compensation related to RSUs was $99.5 million and is expected to be recognized over a weighted-average period of 3.1 years. As of June 30, 2021, the unrecognized stock-based compensation related to PSUs was $2.0 million and is expected to recognized over a weighted-average period of 0.9 years.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2021
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value MeasurementsWe utilize valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. We estimate fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which is categorized in one of the following levels: • Level 1 inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date; • Level 2 inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability; and • Level 3 inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at measurement date. The fair value of the warrant liability was determined using the Black-Scholes valuation methodology and the quoted price of the Company’s common stock in an active market, a Level 3 measurement. Volatility was based on the actual market activity of the Company’s peer group as well as the Company's historical volatility since the Virgin Galactic Business Combination. The expected life was based on the remaining contractual term of the warrants, and the risk free interest rate was based on the implied yield available on U.S. Treasury Securities with a maturity equivalent to the warrants’ expected life. The Company calculated the estimated fair value of warrants using the following assumptions: As of June 30, 2021 Risk-free interest rate 0.53% Contractual term 3.33 years Expected volatility 85% As of December 31, 2020 Risk-free interest rate 0.25% Contractual term 3.82 years Expected volatility 80% The carrying amounts included in the Condensed Consolidated Balance Sheets under current assets and current liabilities approximate fair value because of the short maturity of these instruments. The following tables summarize the fair value of assets that are recorded in the Company’s Condensed Consolidated Balance Sheets as of June 30, 2021 and December 31, 2020 at fair value on a recurring basis: Fair Value Measurements as of June 30, 2021 Level 1 Level 2 Level 3 (In thousands) Assets: Money Market $ 244,657 $ — $ — Certificate of Deposit 70,838 — — Cash Equivalents 200,364 — — Total assets at fair value $ 515,859 $ — $ — Liabilities: Warrant Liability $ — $ — $ 100,347 Total Liabilities $ — $ — $ 100,347 Fair Value Measurements as of December 31, 2020 Level 1 Level 2 Level 3 (In thousands) Assets: Money Market $ 357,463 $ — $ — Certificate of Deposit 93,802 — — Cash Equivalents 200,364 — — Total asset at fair value $ 651,629 $ — $ — Liabilities: Warrant Liability $ — $ — $ 135,440 Total Liabilities $ — $ — $ 135,440

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Legal Proceedings From time to time, the Company is a party to various lawsuits, claims and other legal proceedings that arise in the ordinary course of business. The Company applies accounting for contingencies to determine when and how much to accrue for and disclose related to legal and other contingencies. Accordingly, the Company discloses contingencies deemed to be reasonably possible and accrues loss contingencies when, in consultation with legal advisors, it is concluded that a loss is probable and reasonably estimable. Although the ultimate aggregate amount of monetary liability or financial impact with respect to these matters is subject to many uncertainties and is therefore not predictable with assurance, management believes that any monetary liability or financial impact to the Company from these matters, individually and in the aggregate, beyond that provided at June 30, 2021, would not be material to the Company’s financial position, results of operations or cash flows. However, there can be no assurance with respect to such result, and monetary liability or financial impact to the Company from legal proceedings, lawsuits and other claims could differ materially from those projected. In September 2018, a former contractor employed through a third party staffing agency, alleged on behalf of himself and other aggrieved employees that the Company and the staffing agency, purportedly violated California state wage and hour laws. In March 2020, the Company agreed to settle this matter for $1.9 million. For the three months ended June 30, 2021 and 2020, the Company did not record additional legal settlement expense. There was no additional legal settlement expense recorded for the six months ended June 30, 2021. For the six months ended June 30, 2020, the Company recorded an additional legal settlement expense of approximately $0.2 million, which was recorded in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations and Comprehensive Loss . As of June 30, 2021, the Company has an outstanding $1.9 million payable pending final court motions that has been delayed due to COVID-19. The settlement payment was made in full in July 2021.

Employee Benefit Plan

Employee Benefit Plan	6 Months Ended
	Jun. 30, 2021
Retirement Benefits [Abstract]
Employee Benefit Plan	Employee Benefit Plan The Company has defined contribution plans, under which the Company pays fixed contributions into a separate entity, and additional contributions to the plans are based upon a percentage of the employees’ elected contributions. The Company will have no legal or constructive obligation to pay further amounts. Obligations for contributions to defined contribution plans are recognized within selling, general, and administrative expenses and research and development in the Condensed Consolidated Statements of Operations and Comprehensive Loss , as incurred. Defined contributions were $1.5 million and $1.0 million for the three months ended June 30, 2021 and 2020, respectively. Defined contributions were $2.6 million and $2.0 million for the six months ended June 30, 2021 and 2020, respectively.

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	6 Months Ended
	Jun. 30, 2021
Supplemental Cash Flow Elements [Abstract]
Supplemental Cash Flow Information	Supplemental Cash Flow Information Six Months Ended June 30, 2021 2020 (As Restated) (in thousands) Supplemental disclosure Cash payments for: Income tax paid $ 58 $ 34 $ 58 $ 34 Schedule for noncash investing activities: Unpaid property, plant, and equipment received $ 270 $ 1,287 $ 270 $ 1,287 Schedule for noncash financing activities: Issuance of common stock through "cashless" warrants exercised $ 104,176 $ 360,742 Issuance of common stock through restricted stock units vested 27,320 — Long-term debt — 930 Unpaid deferred transaction costs 250 — $ 131,746 $ 361,672

Subsequent Event

Subsequent Event	6 Months Ended
	Jun. 30, 2021
Subsequent Events [Abstract]
Subsequent Event	Subsequent Events On July 12, 2021, we entered into a distribution agency agreement (the “Distribution Agency Agreement”) with Credit Suisse Securities (USA) LLC, Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC (each, an “Agent” and collectively, the “Agents”) providing for the offer and sale of up to $500.0 million of shares of the Company’s common stock, par value $0.0001 per share, through an "at the market offering" program ("ATM"), from time to time by the Company through the Agents, acting as the Company’s sales agents, or directly to one or more of the Agents, acting as principal. On July 16, 2021, we completed the ATM, generating $500.0 million in gross proceeds, before deducting $6.2 million in underwriting discounts and commissions, and other expenses payable by the Company, through the sale of 13,740,433 shares of common stock We intend to use the net proceeds generated from the ATM for general corporate purposes, including working capital, general and administrative matters and capital expenditures for our manufacturing capabilities, development of our spaceship fleet and other infrastructure improvements. On July 19, 2021, the Company paid the $1.9 million legal settlement related to a former contractor employed through a third party staffing agency, as noted in 15. Commitments and Contingencies .

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2021
Accounting Policies [Abstract]
Restatement of Previously Issued Financial Statements	Restatement of Previously Issued Financial Statements Warrant liability As previously disclosed in Amendment No. 2 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2020 (the "Amendment No. 2 to Form 10-K"), the Company has restated its financial statements as of December 31, 2020 and 2019, for the years ended December 31, 2020 and 2019, as well as the summarized unaudited quarterly financial data for each of the quarterly periods from March 31, 2019 through December 31, 2020, to correct misstatements in those prior periods related to the accounting for warrants, under the guidance of Accounting Standards Codification (“ASC”) 815-40, Contracts in Entity’s Own Equity. The following tables represent the estimated fair value of the Company’s public and private warrant liabilities recorded on our balance sheet along with changes in fair value which are recorded as other income and expense on our statement of operations and the fair value of common stock issued on the date of exercise, which were recorded as additional paid in capital. Public Warrants Private Placement Warrants Total (In thousands) Warranty Liability at December 31, 2019 77,050 47,280 124,330 Redemption/Exercise of Warrants (341,001) — (341,001) Change in Fair Value 283,296 33,600 316,896 Warrant Liability at March 31, 2020 19,345 80,880 100,225 Redemption/Exercise of Warrants (19,741) (19,741) Change in Fair Value 396 9,200 9,596 Warrant Liability at June 30, 2020 — 90,080 90,080 Warranty Liability at December 31, 2020 — 135,440 135,440 Change in Fair Value — 48,719 48,719 Warrant Liability at March 31, 2021 — 184,159 184,159 Redemption/Exercise of Warrants — (104,175) (104,175) Change in Fair Value — 20,363 20,363 Warrant Liability at June 30, 2021 — 100,347 100,347
Basis of Presentation	Basis of PresentationThese condensed consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). All intercompany transactions and balances between the various legal entities comprising the Company have been eliminated in consolidation. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.
Use of Estimates	Use of EstimatesThe preparation of the consolidated financial statements in conformity with GAAP required us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We base these estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results may differ materially from these estimates. Significant estimates inherent in the preparation of the consolidated financial statements include, but are not limited to, accounting for revenue, cost of revenue, contract assets, contract liabilities, useful lives of property, plant and equipment, net, accrued liabilities, income taxes including deferred tax assets and liabilities and impairment valuation, warrants, stock-based awards and contingencies.
Revenue Recognition	Revenue Recognition We recognize revenue when control of the promised service is transferred to our customers in an amount that reflects the consideration we expect to receive based on the contracted amount for those services. Our contracts generally include spaceflight operations and other revenue and engineering services revenue. Spaceflight operations and other revenue Spaceflight operations and other revenue is recognized for providing human spaceflights and carrying payload cargo into space, or a combination of the two. In addition, we have various sponsorship arrangements for which revenue is recognized over the sponsorship term. Human spaceflight services are those services provided to the majority of our customers. Spaceflight service revenue is recognized at a point in time upon successful completion of a spaceflight. Payload cargo services generally include performance obligations in which control is transferred over time. We recognize revenue on these fixed fee contracts, over time, using the proportion of actual costs incurred to the total costs expected to complete the performance obligations. In contracts which include a combination of services, the Company assesses and accounts for individual services separately if they are distinct performance obligations, which often requires judgment based upon knowledge of the services and structure of the sales contract. We allocate the contract price to each performance obligation based on the estimated standalone selling price using observable pricing from our contracts with single performance obligations. Engineering services revenue Engineering services revenue is recognized for providing services for the research, design, development, manufacture, integration and sustainment of advanced technology aerospace systems, products and services. We have arrangements as a subcontractor to the primary contractor of a long-term contract with the U.S. Government and perform the specified work on a time-and-materials basis subject to a guaranteed maximum price. Our engineering services revenue contract obligates us to provide services that together are one distinct performance obligation; the delivery of engineering services. The Company elected to apply the ‘as-invoiced’ practical expedient to such revenues, and as a result, will bypass estimating the variable transaction price. Revenue is recognized as control of the performance obligation is transferred over time to the customer. Variable consideration We generally estimate variable consideration and refund liabilities at the most likely amount to which we expect to be entitled or owed and in certain cases based on the expected value, which requires judgment. Estimated variable consideration amounts are included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. Estimated refund liability amounts are excluded in the transaction price to the extent it is probable that they are payable to the customer. Our estimates of variable consideration and refund liabilities, and determination of whether to include the estimated amounts in the transaction price are based largely on an assessment of our anticipated performance and all information that is reasonably available to us. Disaggregation of revenue The Company does not disaggregate revenue for purposes of disclosure. Contract balances Contract assets are comprised of billed accounts receivable and unbilled receivables, which is the result of timing of revenue recognition, billings and cash collections. The Company records accounts receivable when it has an unconditional right to consideration. Contract liabilities relate to spaceflight operations and other revenue contracts and are recorded when cash payments are received or due in advance of performance. Cash payments for spaceflight services are classified as customer deposits until enforceable rights and obligations exist, when such deposits also become nonrefundable. Customer deposits become nonrefundable and are recorded as deferred revenue following the Company's delivery of the conditions of carriage to the customer and execution of an informed consent. As of June 30, 2021 and December 31, 2020, our contract liabilities are 82.0 million and $83.2 million, respectively. As of June 30, 2021, the contract liabilities are comprised of customer deposits for our spaceflight services of $81.7 million and $0.3 million for our payload contracts. As of December 31, 2020, the contract liabilities are comprised of customer deposits for our spaceflight services of $82.7 million and $0.6 million for our payload contracts. Contract fulfillment costs The Company evaluates whether or not we should capitalize the costs of fulfilling a contract. Such costs would be capitalized when they are not within the scope of other standards and: (1) are directly related to a contract; (2) generate or enhance resources that will be used to satisfy performance obligations; and (3) are expected to be recovered. Significant financing component In determining the transaction price, the Company adjusts the promised amount of consideration for the effects of the time value of money when the timing of payments provides it with a significant benefit of financing the transfers of goods or services to the customer. In those circumstances, the contract contains a significant financing component. When adjusting the promised amount of consideration for a significant financing component, the Company uses the discount rate that would be reflected in a separate financing transaction between the entity and its customer at contract inception and recognizes the revenue amount on a straight-line basis over the term of the Customer Agreement, and interest expense using the effective interest rate method. When the time period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service is not more than one year, the Company applies the significant financing component practical expedient and do not adjust the promised amount of consideration. Remaining performance obligations We do not disclose information about remaining performance obligations for (a) contracts with an original expected length of one year or less, (b) revenues recognized at the amount at which we have the right to invoice for services performed, or (c) variable consideration allocated to wholly unsatisfied performance obligations.
Warrant Liability	Warrant liability The Company classifies its public and private placement warrants as liabilities in accordance with ASC 815 (Derivatives and Hedging). The warrant liability is recorded on the consolidated balance sheet at fair value on the issue date, with subsequent changes in their fair value recognized in the consolidated statement of operations at each reporting date. The Company determined the fair value of its public warrants, which traded in active markets, using quoted market prices for identical instruments. The Company determines the fair value of the private placement warrants using a Black-Scholes option model and the quoted price of the Company’s common stock in an active market, a Level 3 measurement. Volatility is based on the actual market activity of the Company’s peer group as well as the Company's historical volatility since the Virgin Galactic Business Combination. The expected life is based on the remaining contractual term of the warrants, and the risk free interest rate is based on the implied yield available on U.S. Treasury Securities with a maturity equivalent to the warrants’ expected life.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Changes to GAAP are established by the Financial Accounting Standards Board (“FASB”) in the form of Accounting Standards Updates (“ASU”). (a) Issued Accounting Standard Updates Not Yet Adopted In August 2020, the FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity , which simplifies and clarifies certain calculation and presentation matters related to convertible and equity and debt instruments. Specifically, ASU-2020-06 removes requirements to separately account for conversion features as a derivative under ASC Topic 815 and removing the requirement to account for beneficial conversion features on such instruments. Accounting Standards Update 2020-06 also provides clearer guidance surrounding disclosure of such instruments and provides specific guidance for how such instruments are to be incorporated in the calculation of Diluted EPS. The guidance under ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. The Company is currently evaluating the impact of ASU 2020-06 to its financial statements. In January 2021, the FASB issued ASU 2021-01 - Reference Rate Reform , which clarifies that certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivatives that are affected by the discounted transition. This update is effective immediately. We have evaluated and determined the update has no impact to the Company's condensed consolidated financial statements. In May 2021, the FASB issued ASU 2021-04, Earning Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic 470-50), Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40), which clarified and reduced diversity in an issuer's accounting for modifications of exchanges of freestanding equity-classified written call options (such as warrants) that remain equity classified after modification or exchange. This update is effective for all entities for fiscal years beginning after December 15, 2021. We are currently evaluating the impact of ASU 2021-04 to our condensed consolidated financial statements. (b) Adopted Accounting Standard Updates In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes. In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740) , which affects general principles within Topic 740, and are meant to simplify and reduce the cost of accounting for income taxes. It removes certain exceptions to the general principles in Topic 740 and simplifies areas including franchise taxes that are partially based on income, transactions with a government that result in a step up in the tax basis of goodwill, the incremental approach for intraperiod tax allocation, interim period income tax accounting for year-to-date losses that exceed anticipated losses and enacted changes in tax laws in interim periods. The Company adopted the new guidance effective January 1, 2021. The adoption of the new guidance did not have a material impact to the Company's condensed consolidated financial statements.

Organization and its wholly o_2

Organization and its wholly owned subsidiaries ("VGH, Inc.") (Tables)	6 Months Ended
	Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Fair Value	The following tables represent the estimated fair value of the Company’s public and private warrant liabilities recorded on our balance sheet along with changes in fair value which are recorded as other income and expense on our statement of operations and the fair value of common stock issued on the date of exercise, which were recorded as additional paid in capital. Public Warrants Private Placement Warrants Total (In thousands) Warranty Liability at December 31, 2019 77,050 47,280 124,330 Redemption/Exercise of Warrants (341,001) — (341,001) Change in Fair Value 283,296 33,600 316,896 Warrant Liability at March 31, 2020 19,345 80,880 100,225 Redemption/Exercise of Warrants (19,741) (19,741) Change in Fair Value 396 9,200 9,596 Warrant Liability at June 30, 2020 — 90,080 90,080 Warranty Liability at December 31, 2020 — 135,440 135,440 Change in Fair Value — 48,719 48,719 Warrant Liability at March 31, 2021 — 184,159 184,159 Redemption/Exercise of Warrants — (104,175) (104,175) Change in Fair Value — 20,363 20,363 Warrant Liability at June 30, 2021 — 100,347 100,347

Inventory (Tables)

Inventory (Tables)	6 Months Ended
	Jun. 30, 2021
Inventory Disclosure [Abstract]
Schedule of Inventory	As of June 30, 2021 and December 31, 2020, inventory is comprised of the following: As of June 30, 2021 December 31, 2020 (Unaudited) (In thousands) Raw Materials $ 21,938 $ 22,963 Spare parts 8,027 7,520 Total inventory $ 29,965 $ 30,483

Property, Plant, and Equipmen_2

Property, Plant, and Equipment, net (Tables)	6 Months Ended
	Jun. 30, 2021
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant, and Equipment	As of June 30, 2021 and December 31, 2020, property, plant, and equipment, net consisted of the following: As of June 30, 2021 December 31, 2020 (Unaudited) (In thousands) Buildings $ 9,117 $ 9,142 Leasehold improvements 28,914 28,744 Aircraft 195 195 Machinery and equipment 35,709 34,330 IT software and equipment 23,011 22,042 Construction in progress 655 1,780 97,601 96,233 Less accumulated depreciation and amortization (48,731) (43,085) Property, plant, and equipment, net $ 48,870 $ 53,148

Leases (Tables)

Leases (Tables)	6 Months Ended
	Jun. 30, 2021
Leases [Abstract]
Summary of Lease Expense and Cash Flow Information	The components of lease expense related to leases for the periods presented below are as follows: Three Months Ended 2021 2020 (Unaudited and in thousands) Lease Cost: Operating lease expense $ 1,254 $ 1,010 Short-term lease expense 8 26 Finance Lease Cost: Amortization of right-of-use assets 35 28 Interest on lease liabilities 7 8 Total finance lease cost 42 36 Variable lease cost 1,372 427 Total lease cost $ 2,676 $ 1,499 Six Months Ended 2021 2020 (Unaudited and in thousands) Lease Cost: Operating lease expense $ 2,514 $ 2,162 Short-term lease expense 20 123 Finance Lease Cost: Amortization of right-of-use assets 69 55 Interest on lease liabilities 14 17 Total finance lease cost 83 72 Variable lease cost 2,710 775 Total lease cost $ 5,327 $ 3,132 The components of supplemental cash flow information related to leases for the period are as follows: Six Months Ended June 30, 2021 2020 (In thousands, except term and rate data) Cash flow information: Operating cash flows for operating leases $ 2,712 $ 2,545 Operating cash flows for finance leases $ 14 $ 18 Financing cash flows for finance leases $ 69 $ 49 Non-cash activity: Right-of-use assets obtained in exchange for lease obligations Operating leases $ 501 $ 34 Finance Leases $ 19 $ 48 Other Information: Weighted average remaining lease term: Operating leases (in years) 12.37 13.20 Finance leases (in years) 2.49 3.47 Weighted average discount rates: Operating leases 11.65 % 11.77 % Finance leases 8.26 % 8.92 %
Summary of Balance Sheet Information	The supplemental balance sheet information related to leases for the period is as follows: As of June 30, 2021 December 31, 2020 (Unaudited) (In thousands) Operating leases Long-term right-of-use assets $ 19,055 $ 19,555 Short-term operating lease liabilities $ 2,138 $ 2,384 Long-term operating lease liabilities 23,701 24,148 Total operating lease liabilities $ 25,839 $ 26,532
Summary of Operating Lease Maturities	Future minimum lease payments under non-cancelable operating leases (with initial or remaining lease terms in excess of one year) and future minimum finance lease payments as of June 30, 2021 are as follows: Operating Leases Finance (In thousands) 2021 (for the remaining period) $ 4,948 $ 157 2022 4,001 119 2023 3,969 79 2024 3,891 — 2025 3,833 — Thereafter 28,936 — Total lease payments $ 49,578 $ 355 Less: Imputed interest/present value discount (23,739) $ (33) Present value of lease liabilities $ 25,839 $ 322
Summary of Finance Lease Maturities	Future minimum lease payments under non-cancelable operating leases (with initial or remaining lease terms in excess of one year) and future minimum finance lease payments as of June 30, 2021 are as follows: Operating Leases Finance (In thousands) 2021 (for the remaining period) $ 4,948 $ 157 2022 4,001 119 2023 3,969 79 2024 3,891 — 2025 3,833 — Thereafter 28,936 — Total lease payments $ 49,578 $ 355 Less: Imputed interest/present value discount (23,739) $ (33) Present value of lease liabilities $ 25,839 $ 322

Accrued Expenses (Tables)

Accrued Expenses (Tables)	6 Months Ended
	Jun. 30, 2021
Payables and Accruals [Abstract]
Schedule of Accrued Expenses	A summary of the components of accrued liabilities are as follows: As of June 30, 2021 December 31, 2020 (Unaudited) (In thousands) Accrued bonus 6,258 6,892 Other accrued expenses 18,106 16,090 Total accrued expenses $ 24,364 $ 22,982

Long-term Debt (Tables)

Long-term Debt (Tables)	6 Months Ended
	Jun. 30, 2021
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments	As of June 30, 2021 December 31, 2020 (Unaudited) (In thousands) Commercial loan $ 620 $ 620 620 620 Less: Current portion (310) (310) Non-current portion $ 310 $ 310
Schedule of Maturities of Long-term Debt	Aggregate maturities of long-term debt as of June 30, 2021 are as follows: (In thousands) 2021 (for the remaining period) $ 310 2022 310 $ 620

Earnings Per Share (Tables)

Earnings Per Share (Tables)	6 Months Ended
	Jun. 30, 2021
Earnings Per Share [Abstract]
Schedule of Earnings Per Share	The following table presents net loss per share and related information: Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 (As Restated) (As Restated) (In thousands, except for share and per share data) Basic and diluted: Net loss $ (94,040) $ (71,973) $ (223,734) $ (448,709) Weighted average shares of common stock outstanding 240,733,497 211,784,541 238,774,515 207,097,047 Basic and diluted net loss per share $ (0.39) $ (0.34) $ (0.94) $ (2.17)

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	6 Months Ended
	Jun. 30, 2021
Share-based Payment Arrangement [Abstract]
Schedule of Options Outstanding	The following table sets forth the summary of options activity for the six month ended June 30, 2021 under the 2019 Plan (dollars in thousands except per share data): Number of Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Life (in years) Aggregate Intrinsic Value (1) Options outstanding at December 31, 2020 6,796,045 $ 13.59 8.64 68,888 Granted — — Exercised (1,013,402) 13.01 Forfeited options (588,999) 13.93 Options outstanding at June 30, 2021 5,193,644 $ 13.67 7.53 167,604 Options exercisable at June 30, 2021 1,916,745 $ 13.49 7.34 62,305 (1) Aggregate intrinsic value is calculated based on the difference between our closing stock price at period end and the exercise price, multiplied by the number of in-the-money options and represents the pre-tax amount that would have been received by the option holders, had they all exercised all their options on the period end date.
Schedule of Restricted Stock Units Activity	The following table sets forth the summary of RSUs activity during the six months ended June 30, 2021 under the 2019 Plan (dollars in thousands except per share data): Shares Weighted Average Fair Value Outstanding at December 31, 2020 4,760,784 $ 19.63 Granted 680,784 40.41 Vested (709,404) 16.20 Forfeited (713,766) 16.72 Outstanding at June 30, 2021 4,018,398 $ 24.21
Schedule of Performance Stock Unit Activity	The following table summarizes the details of the performance stock units: Shares Weighted Average Fair Value PSUs outstanding at December 31, 2020 — $ — Granted 84,626 29.88 PSUs outstanding at June 30, 2021 84,626 $ 29.88
Summary of Stock Option and RSU Expense	Stock options, RSUs and PSUs expenses are included in selling, general and administrative and research and development expense in the Condensed Consolidated Statements of Operations and Comprehensive Loss as follows: Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Stock option expense Selling, General & Administrative 1,870 1,880 10,856 3,944 Research & Development 825 1,017 1,668 2,056 Total stock option expense 2,695 2,897 12,524 6,000 RSU expense Selling, General & Administrative 7,982 1,666 17,035 2,473 Research & Development 3,172 962 6,402 1,477 Total RSU expense 11,154 2,628 23,437 3,950 PSU expense Selling, General & Administrative $ 574 $ — $ 574 $ — Total PSU expense $ 574 $ — $ 574 $ — Total stock-based compensation expense $ 14,423 $ 5,525 $ 36,535 $ 9,950

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2021
Fair Value Disclosures [Abstract]
Schedule of Valuation Assumptions	The Company calculated the estimated fair value of warrants using the following assumptions: As of June 30, 2021 Risk-free interest rate 0.53% Contractual term 3.33 years Expected volatility 85% As of December 31, 2020 Risk-free interest rate 0.25% Contractual term 3.82 years Expected volatility 80%
Schedule of Fair Value of Assets Measured on Recurring Basis	The following tables summarize the fair value of assets that are recorded in the Company’s Condensed Consolidated Balance Sheets as of June 30, 2021 and December 31, 2020 at fair value on a recurring basis: Fair Value Measurements as of June 30, 2021 Level 1 Level 2 Level 3 (In thousands) Assets: Money Market $ 244,657 $ — $ — Certificate of Deposit 70,838 — — Cash Equivalents 200,364 — — Total assets at fair value $ 515,859 $ — $ — Liabilities: Warrant Liability $ — $ — $ 100,347 Total Liabilities $ — $ — $ 100,347 Fair Value Measurements as of December 31, 2020 Level 1 Level 2 Level 3 (In thousands) Assets: Money Market $ 357,463 $ — $ — Certificate of Deposit 93,802 — — Cash Equivalents 200,364 — — Total asset at fair value $ 651,629 $ — $ — Liabilities: Warrant Liability $ — $ — $ 135,440 Total Liabilities $ — $ — $ 135,440

Supplemental Cash Flow Inform_2

Supplemental Cash Flow Information (Tables)	6 Months Ended
	Jun. 30, 2021
Supplemental Cash Flow Elements [Abstract]
Schedule of Supplemental Cash Flow Information	Six Months Ended June 30, 2021 2020 (As Restated) (in thousands) Supplemental disclosure Cash payments for: Income tax paid $ 58 $ 34 $ 58 $ 34 Schedule for noncash investing activities: Unpaid property, plant, and equipment received $ 270 $ 1,287 $ 270 $ 1,287 Schedule for noncash financing activities: Issuance of common stock through "cashless" warrants exercised $ 104,176 $ 360,742 Issuance of common stock through restricted stock units vested 27,320 — Long-term debt — 930 Unpaid deferred transaction costs 250 — $ 131,746 $ 361,672

Organization and its wholly o_3

Organization and its wholly owned subsidiaries ("VGH, Inc.") - Warrant Liability (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2021	Jun. 30, 2020
Warrant Liability [Roll Forward]
Beginning balance	$ 184,159	$ 135,440	$ 100,225	$ 124,330	$ 135,440	$ 124,330
Redemption/Exercise of Warrants	(104,175)		(19,741)	(341,001)
Change in fair value of warrants	20,363	48,719	9,596	316,896	69,082	326,492
Ending balance	100,347	184,159	90,080	100,225	100,347	90,080
Public Warrants
Warrant Liability [Roll Forward]
Beginning balance	0	0	19,345	77,050	0	77,050
Redemption/Exercise of Warrants	0		(19,741)	(341,001)
Change in fair value of warrants	0	0	396	283,296
Ending balance	0	0	0	19,345	0	0
Private Placement Warrants
Warrant Liability [Roll Forward]
Beginning balance	184,159	135,440	80,880	47,280	135,440	47,280
Redemption/Exercise of Warrants	(104,175)			0
Change in fair value of warrants	20,363	48,719	9,200	33,600
Ending balance	$ 100,347	$ 184,159	$ 90,080	$ 80,880	$ 100,347	$ 90,080

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Narrative) (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Related Party Transaction [Line Items]
Customer deposits	$ 81,960	$ 83,211
Spaceflight operations
Related Party Transaction [Line Items]
Customer deposits	81,700	82,700
Payload Contracts
Related Party Transaction [Line Items]
Customer deposits	$ 300	$ 600

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Related Party Transaction [Line Items]
Royalty payable, as a percentage of revenue	1.00%		1.00%
Royalty payable, quarterly amount	$ 40		$ 40
Sponsorship royalties payable, as a percentage of revenue	25.00%		25.00%
Affiliated Entity | License and royalty fees
Related Party Transaction [Line Items]
Expenses from related party	$ 40	$ 40	$ 80	$ 95
Subsidiary of Common Parent
Related Party Transaction [Line Items]
Related party (payable) receivable	2		2		$ 85
Subsidiary of Common Parent | Allocation of corporate expenses
Related Party Transaction [Line Items]
Transaction amounts from related party	$ 31	$ 99	$ 71	$ 236

Inventory (Schedule of Inventor

Inventory (Schedule of Inventory) (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Inventory Disclosure [Abstract]
Raw Materials	$ 21,938	$ 22,963
Spare parts	8,027	7,520
Total inventory	$ 29,965	$ 30,483

Inventory (Narrative) (Details)

Inventory (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Inventory Disclosure [Abstract]
Inventory write-down	$ 0.1	$ 0.1	$ 0.2	$ 1.1

Property, Plant, and Equipmen_3

Property, Plant, and Equipment, net (Schedule of Property, Plant, and Equipment) (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Property, Plant and Equipment [Line Items]
Property, plant, and equipment	$ 97,601	$ 96,233
Less accumulated depreciation and amortization	(48,731)	(43,085)
Property, plant, and equipment, net	48,870	53,148
Buildings
Property, Plant and Equipment [Line Items]
Property, plant, and equipment	9,117	9,142
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant, and equipment	28,914	28,744
Aircraft
Property, Plant and Equipment [Line Items]
Property, plant, and equipment	195	195
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property, plant, and equipment	35,709	34,330
IT software and equipment
Property, Plant and Equipment [Line Items]
Property, plant, and equipment	23,011	22,042
Construction in progress
Property, Plant and Equipment [Line Items]
Property, plant, and equipment	$ 655	$ 1,780

Property, Plant, and Equipmen_4

Property, Plant, and Equipment, net (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Property, Plant and Equipment [Line Items]
Depreciation and amortization	$ 2,900	$ 2,500	$ 5,740	$ 4,489
Research & Development
Property, Plant and Equipment [Line Items]
Depreciation and amortization	$ 1,300	$ 1,100	$ 2,600	$ 2,100

Leases (Lease Cost) (Details)

Leases (Lease Cost) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Leases [Abstract]
Operating lease expense	$ 1,254	$ 1,010	$ 2,514	$ 2,162
Short-term lease expense	8	26	20	123
Finance Lease Cost:
Amortization of right-of-use assets	35	28	69	55
Interest on lease liabilities	7	8	14	17
Total finance lease cost	42	36	83	72
Variable lease cost	1,372	427	2,710	775
Total lease cost	$ 2,676	$ 1,499	$ 5,327	$ 3,132

Leases (Cash Flow Information)

Leases (Cash Flow Information) (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Cash Flow, Operating Activities, Lessee [Abstract]
Operating cash flows for operating leases	$ 2,712	$ 2,545
Operating cash flows for finance leases	14	18
Financing cash flows for finance leases	69	49
Right-of-use assets obtained in exchange for lease obligations
Operating leases	501	34
Finance Leases	$ 19	$ 48
Weighted average remaining lease term:
Operating leases (in years)	12 years 4 months 13 days	13 years 2 months 12 days
Finance leases (in years)	2 years 5 months 26 days	3 years 5 months 19 days
Weighted average discount rates:
Operating leases	11.65%	11.77%
Finance leases	8.26%	8.92%

Leases (Supplemental Balance Sh

Leases (Supplemental Balance Sheet) (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Leases [Abstract]
Long-term right-of-use assets	$ 19,055	$ 19,555
Short-term operating lease liabilities	2,138	2,384
Long-term operating lease liabilities	23,701	24,148
Total operating lease liabilities	$ 25,839	$ 26,532

Leases (Narrative) (Details)

Leases (Narrative) (Details)	Jun. 30, 2021
Minimum
Lessee, Lease, Description [Line Items]
Operating lease, renewal term	3 years
Maximum
Lessee, Lease, Description [Line Items]
Operating lease, renewal term	20 years

Leases (Lease Maturities) (Deta

Leases (Lease Maturities) (Details) $ in Thousands	Jun. 30, 2021USD ($)
Operating Leases
2021 (for the remaining period)	$ 4,948
2022	4,001
2023	3,969
2024	3,891
2025	3,833
Thereafter	28,936
Total lease payments	49,578
Imputed interest/present value discount	(23,739)
Present value of lease liabilities	25,839
Finance Leases
2021 (for the remaining period)	157
2022	119
2023	79
2024	0
2025	0
Thereafter	0
Total lease payments	355
Imputed interest/present value discount	(33)
Present value of lease liabilities	$ 322

Accrued Expenses (Details)

Accrued Expenses (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Payables and Accruals [Abstract]
Accrued bonus	$ 6,258	$ 6,892
Other accrued expenses	18,106	16,090
Total accrued expenses	$ 24,364	$ 22,982

Long-term Debt (Schedule of Deb

Long-term Debt (Schedule of Debt) (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
Total debt	$ 620	$ 620
Less: Current portion	(310)	(310)
Non-current portion	310	310
Commercial loan | Commercial loan
Debt Instrument [Line Items]
Total debt	$ 620	$ 620

Long-term Debt (Schedule of Mat

Long-term Debt (Schedule of Maturities) (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Debt Disclosure [Abstract]
2021 (for the remaining period)	$ 310
2022	310
Total debt	$ 620	$ 620

Long-term Debt (Narrative) (Det

Long-term Debt (Narrative) (Details) - Commercial loan - Commercial loan $ in Millions	27 Months Ended
	Oct. 01, 2022USD ($)	Jun. 18, 2020USD ($)installment
Debt Instrument [Line Items]
Loans payable		$ 0.9
Number of installments | installment		3
Interest rate		0.00%
Forecast
Debt Instrument [Line Items]
Annual payment	$ 0.3

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Income Tax Disclosure [Abstract]
Income tax (expense) benefit	$ (6)	$ (40)	$ (49)	$ 6
Effective income tax rate	0.00%	0.00%

Stockholders' Equity (Details)

Stockholders' Equity (Details) - USD ($) $ / shares in Units, $ in Thousands	Mar. 13, 2020	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Class of Warrant or Right [Line Items]
Redemption price per warrant (in dollars per share)	$ 0.01							$ 0.01
Number of shares acquired by each warrant (in shares)	0.5073
Warrants redeemed (in shares)								295,305
Change in fair value of warrants		$ (20,363)	$ (48,719)	$ (9,596)	$ (316,896)	$ (69,082)	$ (326,492)
Warrant liability		$ 100,347	184,159	90,080	100,225	$ 100,347	90,080	$ 100,347	$ 135,440	$ 124,330
Public Warrants
Class of Warrant or Right [Line Items]
Outstanding warrants (in shares)		0				0		0
Change in fair value of warrants		$ 0	0	(396)	(283,296)
Warrant liability		$ 0	$ 0	$ 0	$ 19,345	$ 0	$ 0	$ 0	$ 0	$ 77,050
Private Placement
Class of Warrant or Right [Line Items]
Outstanding warrants (in shares)		2,666,667				2,666,667		2,666,667	8,000,000

Earnings Per Share (Schedule of

Earnings Per Share (Schedule of Earnings Per Share) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Basic and diluted:
Net loss	$ (94,040)	$ (71,973)	$ (223,734)	$ (448,709)
Weighted average shares of common stock outstanding (in shares)	240,733,497	211,784,541	238,774,515	207,097,047
Weighted average shares of common stock outstanding (in shares)	240,733,497	211,784,541	238,774,515	207,097,047
Basic net loss per share (in dollars per share)	$ (0.39)	$ (0.34)	$ (0.94)	$ (2.17)
Diluted net loss per share (in dollars per share)	$ (0.39)	$ (0.34)	$ (0.94)	$ (2.17)

Earnings Per Share (Narrative)

Earnings Per Share (Narrative) (Details) - shares	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential effect of warrants to purchase stock (in shares)	2,666,667	8,000,000

Stock-Based Compensation (Narra

Stock-Based Compensation (Narrative) (Details) - USD ($) $ in Millions	1 Months Ended	6 Months Ended
	Mar. 31, 2021	Jun. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized stock-based compensation expense		$ 28.9
Stock option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage		25.00%
Unrecognized compensation cost, period for recognition		2 years 8 months 12 days
Stock option | 2019 Stock Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period		3 years
Expiration period		10 years
Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period		4 years
Unrecognized compensation cost, period for recognition		3 years 1 month 6 days
Unrecognized stock-based compensation expense, excluding options		$ 99.5
Granted (in shares)		680,784
Restricted stock units | Tranche one
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage		25.00%
Restricted stock units | Tranche two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage		25.00%
Restricted stock units | Tranche three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage		25.00%
Restricted stock units | Tranche four
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage		25.00%
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost, period for recognition		10 months 24 days
Unrecognized stock-based compensation expense, excluding options		$ 2
Granted (in shares)		84,626
Performance Shares | Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)	84,626
Performance Shares | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage		25.00%
Performance Shares | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage		200.00%

Stock-Based Compensation (2019

Stock-Based Compensation (2019 Stock Plan Activity) (Details) - 2019 Stock Plan - USD ($) $ / shares in Units, $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Number of Shares
Beginning balance (in shares)	6,796,045
Granted (in shares)	0
Exercised (in shares)	(1,013,402)
Forfeited options (in shares)	(588,999)
Ending balance (in shares)	5,193,644	6,796,045
Options exercisable (in shares)	1,916,745
Weighted Average Exercise Price
Weighted-average exercise price, beginning (in dollars per share)	$ 13.59
Granted (in dollars per share)	0
Exercised (in dollars per share)	13.01
Forfeited options (in dollars per share)	13.93
Weighted-average exercise price, ending (in dollars per share)	13.67	$ 13.59
Options exercisable (in dollars per share)	$ 13.49
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Options outstanding, weighted average contractual term	7 years 6 months 10 days	8 years 7 months 20 days
Options exercisable, weighted average contractual term	7 years 4 months 2 days
Options outstanding, aggregate intrinsic value	$ 167,604	$ 68,888
Options exercisable, aggregate intrinsic value	$ 62,305

Stock-Based Compensation (RSU A

Stock-Based Compensation (RSU Activity) (Details) - Restricted stock units	6 Months Ended
	Jun. 30, 2021$ / sharesshares
Shares
Outstanding, beginning balance (in shares) | shares	4,760,784
Granted (in shares) | shares	680,784
Vested (in shares) | shares	(709,404)
Forfeited (in shares) | shares	(713,766)
Outstanding, ending balance (in shares) | shares	4,018,398
Weighted Average Fair Value
Outstanding, beginning balance (in dollars per share) | $ / shares	$ 19.63
Granted (in dollars per share) | $ / shares	40.41
Vested (in dollars per share) | $ / shares	16.20
Forfeited (in dollars per share) | $ / shares	16.72
Outstanding, ending balance (in dollars per share) | $ / shares	$ 24.21

Stock-Based Compensation (PSU A

Stock-Based Compensation (PSU Activity) (Details) - Performance Shares	6 Months Ended
	Jun. 30, 2021$ / sharesshares
Shares
Outstanding, beginning balance (in shares) | shares	0
Granted (in shares) | shares	84,626
Outstanding, ending balance (in shares) | shares	84,626
Weighted Average Fair Value
Outstanding, beginning balance (in dollars per share) | $ / shares	$ 0
Granted (in dollars per share) | $ / shares	29.88
Outstanding, ending balance (in dollars per share) | $ / shares	$ 29.88

Stock-Based Compensation (Compe

Stock-Based Compensation (Compensation Expense) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 14,423	$ 5,525	$ 36,535	$ 9,950
Stock option
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	2,695	2,897	12,524	6,000
Stock option | Selling, General & Administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	1,870	1,880	10,856	3,944
Stock option | Research & Development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	825	1,017	1,668	2,056
Restricted stock units
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	11,154	2,628	23,437	3,950
Restricted stock units | Selling, General & Administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	7,982	1,666	17,035	2,473
Restricted stock units | Research & Development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	3,172	962	6,402	1,477
Performance Shares
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	574	0	574	0
Performance Shares | Selling, General & Administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 574	$ 0	$ 574	$ 0

Fair Value Measurements (Assump

Fair Value Measurements (Assumptions) (Details) - Level 3	Jun. 30, 2021employee	Dec. 31, 2020employee
Risk-free interest rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement inputs	0.0053	0.0025
Contractual term
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contractual term	3 years 3 months 29 days	3 years 9 months 25 days
Expected volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement inputs	0.85	0.80

Fair Value Measurements (Fair V

Fair Value Measurements (Fair Values) (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability	$ 100,347	$ 184,159	$ 135,440	$ 90,080	$ 100,225	$ 124,330
Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets at fair value	515,859		651,629
Warrant liability	0		0
Total Liabilities	0		0
Fair Value, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets at fair value	0		0
Warrant liability	0		0
Total Liabilities	0		0
Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets at fair value	0		0
Warrant liability	100,347		135,440
Total Liabilities	100,347		135,440
Fair Value, Recurring | Money Market | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets:	244,657		357,463
Fair Value, Recurring | Money Market | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets:	0		0
Fair Value, Recurring | Money Market | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets:	0		0
Fair Value, Recurring | Certificate of Deposit | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets:	70,838		93,802
Fair Value, Recurring | Certificate of Deposit | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets:	0		0
Fair Value, Recurring | Certificate of Deposit | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets:	0		0
Fair Value, Recurring | Cash Equivalents | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets:	200,364		200,364
Fair Value, Recurring | Cash Equivalents | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets:	0		0
Fair Value, Recurring | Cash Equivalents | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets:	$ 0		$ 0

Commitments and Contingencies (

Commitments and Contingencies (Narrative) (Details) - USD ($)	1 Months Ended	3 Months Ended		6 Months Ended
	Mar. 31, 2020	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Settlement amount awarded to other party	$ 1,900,000
Settlement expense		$ 0	$ 0	$ 0	$ 200,000
Loss contingency payable		$ 1,900,000		$ 1,900,000

Employee Benefit Plan (Details)

Employee Benefit Plan (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Retirement Benefits [Abstract]
Defined contributions	$ 1.5	$ 1	$ 2.6	$ 2

Supplemental Cash Flow Inform_3

Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Cash payments for:
Income tax paid	$ 58	$ 34
Schedule for noncash investing activities:
Unpaid property, plant, and equipment received	270	1,287
Schedule for noncash financing activities:
Issuance of common stock through "cashless" warrants exercised	104,176	360,742
Issuance of common stock through restricted stock units vested	27,320	0
Long-term debt	0	930
Noncash financing activities	131,746	361,672
Unpaid deferred transaction costs	$ 250	$ 0

Subsequent Event (Details)

Subsequent Event (Details) - USD ($) $ / shares in Units, $ in Millions	Jul. 19, 2021	Jul. 16, 2021	Mar. 31, 2020	Jul. 12, 2021	Jun. 30, 2021	Dec. 31, 2020
Subsequent Event [Line Items]
Common stock, par value (in dollars per share)					$ 0.0001	$ 0.0001
Loss contingency payable					$ 1.9
Settlement amount awarded to other party			$ 1.9
Subsequent Event
Subsequent Event [Line Items]
Value of shares offered (up to)				$ 500
Gross proceeds		$ 500
Stock issuance costs		$ 6.2
Stock sold (in shares)		13,740,433
Settlement amount awarded to other party	$ 1.9